Phase IB Trial of Radium-223 and Niraparib in Patients With Castrate Resistant Prostate Cancer (NiraRad)

Clinical trial NCT03076203 · COMPLETED

Trial details

NCT number: NCT03076203
Sponsor: Sidney Kimmel Comprehensive Cancer Center at Thomas Jefferson University
Status: COMPLETED
Phase: Phase 1
Study type: INTERVENTIONAL

Prostate Carcinoma Metastatic to the Bone Stage IV Prostate Adenocarcinoma Hormone-refractory Prostate Cancer

Start date: 2017-09-22
Primary completion: 2020-01-13
Enrollment: 14

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.